Trial Profile
An Open Label Study to Document the Treatment Effect of 1 and 2% BPX-01 Minocycline Topical Gel in Moderate to Severe Inflammatory Non-nodular Acne Vulgaris (Protocol Number BPX-01-C04)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2022
Price :
$35
*
At a glance
- Drugs Minocycline (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors BioPharmX Corporation
- 04 Jun 2018 Status changed from active, no longer recruiting to completed.
- 16 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.
- 16 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2018.